Patent intelligence · US
US 11938125
Use of Hsp70 as a regulator of enzymatic activity
Use of Hsp70 as a regulator of enzymatic activity
Patent details — US 11938125
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 26, 2024
- Expiration
- Mar 21, 2044
- Applicant
- ZEVRA DENMARK A/S
- Claims
- 5
- CPC classes
- A61K, A61K31/445, A61K31/4545, A61K31/56
Quick answer
US 11938125 (Use of Hsp70 as a regulator of enzymatic activity) is held by ZEVRA DENMARK A/S. Status: granted. Granted Mar 26, 2024. Expires Mar 21, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ZEVRA DENMARK A/S
- Grant date
- Expiration
- Claims
- 5
- CPC classes
- A61K, A61K31/445, A61K31/4545, A61K31/56, A61K33/30, A61K38/16
More from ZEVRA DENMARK A/S
Related pharmaceutical patents in our USPTO index.
-
US 12251445
Gamma-hydroxybutyrate delivering compounds and processes for making and using them
granted -
US 12091386
D-amphetamine compounds, compositions, and processes for making and using the same
granted -
US 12076316
Levorphanol prodrugs and processes for making and using them
granted -
US 12012384
Dextrorphan prodrugs and processes for making and using them
granted
Frequently asked questions
What is US patent 11938125?
US 11938125 (Use of Hsp70 as a regulator of enzymatic activity) is held by ZEVRA DENMARK A/S. Status: granted. Granted Mar 26, 2024. Expires Mar 21, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11938125?
ZEVRA DENMARK A/S is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 5 pharmaceutical patents for this assignee.
When does US 11938125 expire?
Our index shows an expiration date of Mar 21, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.